Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells.
We previously demonstrated that transfecting HeLa cells with the 24 kDa basic fibroblast growth factor-2 (FGF-2) isoform dramatically increased cell survival after irradiation. To investigate genes implicated in this radioresistance acquisition, we compared mRNA expression between radioresistant 24 kDa FGF-2-expressing cells (HeLa 3A) and radiosensitive control HeLa PINA cells using the differential display technique. Of the 32 differentially expressed mRNAs, 1 presented a significant homology with a known gene. This 378 bp fragment presented 100% identity with exon 11 and 12 of human nucleophosmin (NPM) but differed by including a part of intron 9 in its 5' end. The differential expression of this fragment was confirmed using an RNase protection assay. We then cloned the entire corresponding mRNA and showed that it contained all the exons of NPM plus intron 9, suggesting that it was a splicing product of the NPM gene. This variant encoded for a 35-amino acid truncated NPM (NPM2). NPM2 expression was increased in HeLa 3A. To investigate NPM2's role in radioresistance acquisition, we transfected HeLa cells with NPM2 cDNA and analyzed survival after irradiation of the clones obtained. After transfection with NPM2, radiosensitive HeLa cells exhibited a dramatic increase in cell survival after irradiation. Taken together, our results demonstrate that expression of a COOH-truncated NPM form resulting from the alternative splicing of NPM mRNA is able to increase cell survival after irradiation and suggests that it might be involved in cellular response to ionizing radiation.
Dalenc
Florence
F
Laboratoire d'Oncologie Cellulaire et Moléculaire, UPRES-EA 2048, Université Paul Sabatier, Toulouse, France.
Drouet
Jerome
J
Ader
Isabelle
I
Delmas
Caroline
C
Rochaix
Philippe
P
Favre
Gilles
G
Cohen-Jonathan
Elizabeth
E
Toulas
Christine
C
D017398:Alternative Splicing; D001483:Base Sequence; D015153:Blotting, Western; D002470:Cell Survival; D018076:DNA, Complementary / Q000378:metabolism; D004307:Dose-Response Relationship, Radiation; D005091:Exons; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry; D020869:Gene Expression Profiling; D006367:HeLa Cells; D006801:Humans; D007150:Immunohistochemistry; D007438:Introns; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000096:biosynthesis* / Q000737:chemistry*; D000090243:Nucleophosmin; D010957:Plasmids / Q000378:metabolism; D020033:Protein Isoforms; D017434:Protein Structure, Tertiary; D012313:RNA / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D011836:Radiation Tolerance; D011839:Radiation, Ionizing; D014162:Transfection
D018076:DNA, Complementary; C000716967:NPM1 protein, human; D009687:Nuclear Proteins; D020033:Protein Isoforms; D012333:RNA, Messenger; D016222:Fibroblast Growth Factor 2; D000090243:Nucleophosmin; D012313:RNA